Literature DB >> 19661787

Evaluation of 5 different labeled polymer immunohistochemical detection systems.

Ivar Skaland1, Marit Nordhus, Einar Gudlaugsson, Jan Klos, Kjell H Kjellevold, Emiel A M Janssen, Jan P A Baak.   

Abstract

Immunohistochemical staining is important for diagnosis and therapeutic decision making but the results may vary when different detection systems are used. To analyze this, 5 different labeled polymer immunohistochemical detection systems, REAL EnVision, EnVision Flex, EnVision Flex+ (Dako, Glostrup, Denmark), NovoLink (Novocastra Laboratories Ltd, Newcastle Upon Tyne, UK) and UltraVision ONE (Thermo Fisher Scientific, Fremont, CA) were tested using 12 different, widely used mouse and rabbit primary antibodies, detecting nuclear, cytoplasmic, and membrane antigens. Serial sections of multitissue blocks containing 4% formaldehyde fixed paraffin embedded material were selected for their weak, moderate, and strong staining for each antibody. Specificity and sensitivity were evaluated by subjective scoring and digital image analysis. At optimal primary antibody dilution, digital image analysis showed that EnVision Flex+ was the most sensitive system (P < 0.005), with means of 8.3, 13.4, 20.2, and 41.8 gray scale values stronger staining than REAL EnVision, EnVision Flex, NovoLink, and UltraVision ONE, respectively. NovoLink was the second most sensitive system for mouse antibodies, but showed low sensitivity for rabbit antibodies. Due to low sensitivity, 2 cases with UltraVision ONE and 1 case with NovoLink stained false negatively. None of the detection systems showed any distinct false positivity, but UltraVision ONE and NovoLink consistently showed weak background staining both in negative controls and at optimal primary antibody dilution. We conclude that there are significant differences in sensitivity, specificity, costs, and total assay time in the immunohistochemical detection systems currently in use.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19661787     DOI: 10.1097/PAI.0b013e3181b0eaad

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  12 in total

1.  Effects of long-term storage on the detection of proteins, DNA, and mRNA in tissue microarray slides.

Authors:  Christina Karlsson; Mats G Karlsson
Journal:  J Histochem Cytochem       Date:  2011-12       Impact factor: 2.479

2.  High-sensitivity epidermal growth factor receptor immunostaining for colorectal carcinomas, compared with EGFR PharmDx™: a study of diagnostic accuracy.

Authors:  Kazuya Shiogama; Trai Wongsiri; Yasuyoshi Mizutani; Ken-ichi Inada; Yutaka Tsutsumi
Journal:  Int J Clin Exp Pathol       Date:  2012-11-20

3.  Identification of a Subset of Stage I Colorectal Cancer Patients With High Recurrence Risk.

Authors:  Lik Hang Lee; Lindy Davis; Lourdes Ylagan; Angela R Omilian; Kristopher Attwood; Canan Firat; Jinru Shia; Philip B Paty; William G Cance
Journal:  J Natl Cancer Inst       Date:  2022-05-09       Impact factor: 11.816

4.  Tumor necrosis factor-α-accelerated degradation of type I collagen in human skin is associated with elevated matrix metalloproteinase (MMP)-1 and MMP-3 ex vivo.

Authors:  Magnus S Ågren; Reinhild Schnabel; Lise H Christensen; Ursula Mirastschijski
Journal:  Eur J Cell Biol       Date:  2014-10-23       Impact factor: 4.492

5.  Quantitative immunohistochemical assay with novel digital immunostaining for comparisons of PD-L1 antibodies.

Authors:  Takuo Fujisawa; Koji Tsuta; Hiroaki Yanagimoto; Masao Yagi; Kensuke Suzuki; Kenji Nishikawa; Masaru Takahashi; Hisatake Okada; Yasushi Nakano; Hiroshi Iwai
Journal:  Mol Clin Oncol       Date:  2019-01-17

6.  Primary tumor vascularity, HIF-1α and VEGF expression in vulvar squamous cell carcinomas: their relationships with clinicopathological characteristics and prognostic impact.

Authors:  Hari Prasad Dhakal; Jahn M Nesland; Mette Førsund; Claes G Trope; Ruth Holm
Journal:  BMC Cancer       Date:  2013-10-29       Impact factor: 4.430

7.  The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer.

Authors:  Marie Klintman; Carina Strand; Cecilia Ahlin; Sanda Beglerbegovic; Marie-Louise Fjällskog; Dorthe Grabau; Einar Gudlaugsson; Emiel A M Janssen; Kristina Lövgren; Ivar Skaland; Pär-Ola Bendahl; Per Malmström; Jan P A Baak; Mårten Fernö
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

8.  Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis.

Authors:  João Marcos de Azevedo Delou; Giselle Maria Vignal; Vanessa Índio-do-Brasil; Maria Theresa de Souza Accioly; Taiana Sousa Lopes da Silva; Diogo Nascimento Piranda; Marcelo Sobral-Leite; Marcelo Alex de Carvalho; Márcia Alves Marques Capella; Rosane Vianna-Jorge
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-06-10

9.  Characteristics of the tissue section that influence the staining outcome in immunohistochemistry.

Authors:  Sylwia Libard; Dijana Cerjan; Irina Alafuzoff
Journal:  Histochem Cell Biol       Date:  2018-10-24       Impact factor: 4.304

10.  Development of EMab-51, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody in Flow Cytometry, Western Blot, and Immunohistochemistry.

Authors:  Shunsuke Itai; Mika K Kaneko; Yuki Fujii; Shinji Yamada; Takuro Nakamura; Miyuki Yanaka; Noriko Saidoh; Saori Handa; Yao-Wen Chang; Hiroyoshi Suzuki; Hiroyuki Harada; Yukinari Kato
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2017-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.